David Crean Board Member CLSA
David H. Crean, Ph.D is a Managing Director at Objective Capital Partners where he leads the firm’s M&A, partnering, valuations and capital financing transactions with life science and healthcare clients. Dr. Crean has in excess of 25 years of life sciences R&D and corporate development transactional experience in the pharmaceutical industry. Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a Registered Investment Banking Representative of BA Securities LLC, Member FINRA SIPC.
Dr. Crean also serves on several Boards of Directors within the ife sciences industry including the California Life Sciences Association (CLSA). He is also a contributing author for Forbes.com. For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2019, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards.